Cantor Fitzgerald Investment Advisors’s CVS Health CVS Stock Holding History

Cantor Fitzgerald Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.3M	Sell	254,190 -112,178	-31%	-$10M	1.77%	8
2026 Q1	$26.3M	Sell	366,368 -7,579	-2%	-$584K	1.94%	7
2025 Q4	$29.7M	Sell	373,947 -41,566	-10%	-$3.28M	2.2%	7
2025 Q3	$31.3M	Buy	415,513 +5,778	+1%	+$396K	2.13%	7
2025 Q2	$28.3M	Buy	409,735 +6,615	+2%	+$434K	2%	8
2025 Q1	$27.3M	Sell	403,120 -1,323	-0.3%	-$79.2K	1.99%	7
2024 Q4	$18.2M	Buy	404,443 +22,926	+6%	+$1.29M	1.26%	22
2024 Q3	$24M	Buy	381,517 +723	+0.2%	+$42.2K	1.63%	9
2024 Q2	$22.5M	Buy	380,794 +90,746	+31%	+$5.68M	1.73%	11
2024 Q1	$23.1M	Sell	290,048 -5,477	-2%	-$418K	1.72%	12
2023 Q4	$23.3M	Buy	+295,525	New	+$21M	1.8%	10
2022 Q1	$38.2M	Buy	377,875 +181,966	+93%	+$19.1M	1.71%	10
2021 Q4	$20.2M	Buy	195,909 +3,019	+2%	+$279K	1.23%	13
2021 Q3	$16.4M	Sell	192,890 -528	-0.3%	-$44.2K	1.21%	17
2021 Q2	$16.1M	Buy	+193,418	New	+$15.8M	1.19%	17

Other funds holding CVS

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Cantor Fitzgerald Investment Advisors's CVS Position: Q2 2026 in Review

Cantor Fitzgerald Investment Advisors reduced its CVS Health (CVS) stake by 31% in Q2 2026, selling an estimated $10M and leaving 254,190 shares worth $26.3M. The position accounts for 1.77% of the portfolio, ranked #8.

Cantor Fitzgerald Investment Advisors first reported a position in CVS in Q2 2021 and has held it in 15 quarters since. The position peaked at $38.2M in Q1 2022. 912 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Cantor Fitzgerald Investment Advisors held 254,190 shares of CVS Health worth $26.3M as of Q2 2026.
Cantor Fitzgerald Investment Advisors sold 112,178 CVS Health shares in Q2 2026, an estimated $10M.
CVS Health made up 1.77% of Cantor Fitzgerald Investment Advisors's portfolio in Q2 2026, its #8 holding.
Cantor Fitzgerald Investment Advisors first reported a position in CVS Health in Q2 2021 and has held it in 15 quarters since.
Cantor Fitzgerald Investment Advisors's CVS Health position peaked at $38.2M in Q1 2022.
912 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Cantor Fitzgerald Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.